The healthcare industry is a different place than it was even just three years ago. The combined result of the COVID-19 pandemic, regulatory changes, and reimbursement shifts have transformed the landscape for all healthcare industry stakeholders. This presentation will provide an overview of what we anticipate to be the most important topics of 2023 (from investing in behavioral health to increasing private equity and venture capital involvement) and their associated implication for healthcare valuation.